Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/imm.12036

http://scihub22266oqcxt.onion/10.1111/imm.12036
suck pdf from google scholar
23216602!3575763!23216602
unlimited free pdf from europmc23216602    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=23216602&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid23216602      Immunology 2013 ; 138 (2): 105-15
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells #MMPMID23216602
  • Lindau D; Gielen P; Kroesen M; Wesseling P; Adema GJ
  • Immunology 2013[Feb]; 138 (2): 105-15 PMID23216602show ga
  • Myeloid-derived suppressor cells (MDSC) and regulatory T (Treg) cells are major components of the immune suppressive tumour microenvironment (TME). Both cell types expand systematically in preclinical tumour models and promote T-cell dysfunction that in turn favours tumour progression. Clinical reports show a positive correlation between elevated levels of both suppressors and tumour burden. Recent studies further revealed that MDSCs can modulate the de novo development and induction of Treg cells. The overlapping target cell population of Treg cells and MDSCs is indicative for the importance and flexibility of immune suppression under pathological conditions. It also suggests the existence of common pathways that can be used for clinical interventions aiming to manipulate the TME. Elimination or reprogramming of the immune suppressive TME is one of the major current challenges in immunotherapy of cancer. Interestingly, recent findings suggest that natural killer T (NKT) cells can acquire the ability to convert immunosuppressive MDSCs into immunity-promoting antigen-presenting cells. Here we will review the cross-talk between MDSCs and other immune cells, focusing on Treg cells and NKT cells. We will consider its impact on basic and applied cancer research and discuss how targeting MDSCs may pave the way for future immunocombination therapies.
  • |*Immune Tolerance[MESH]
  • |Animals[MESH]
  • |Antigen-Presenting Cells/immunology/pathology[MESH]
  • |Cell Communication/*immunology[MESH]
  • |Humans[MESH]
  • |Immunotherapy/methods[MESH]
  • |Myeloid Cells/*immunology/pathology[MESH]
  • |Natural Killer T-Cells/*immunology/pathology[MESH]
  • |Neoplasms/*immunology/pathology/therapy[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box